Skip to main content

FDA finds poor conditions at contractor's plant for making J&J's COVID-19 vaccine

By The Wall Street Journal  
   April 21, 2021

Inspectors found the Emergent BioSolutions plant didn't maintain clean and sanitary conditions, and didn't follow procedures to prevent contamination.

Full story

Get the latest on healthcare leadership in your inbox.